科研
教育
登录
CN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Department of Infectious Diseases/Virology,
Section Viral Vector Technologies,
Medical Faculty,
BioQuant Center,
BQ0030,
Department of Infectious Diseases/Virology, Section Viral Vector Technologies, Medical Faculty,
BioQuant Center, BQ0030
Olena Maiakovska has not added Biography.
If you are Olena Maiakovska and would like to personalize this page please email our Author Liaison for assistance.
Ex vivo and in vivo suppression of SARS-CoV-2 with combinatorial AAV/RNAi expression vectors.
Molecular therapy : the journal of the American Society of Gene Therapy 05, 2022 | Pubmed ID: 35038579
Determination of AAV properties by single amino acids: Go(o)d is in the details.
Molecular therapy. Methods & clinical development Dec, 2022 | Pubmed ID: 36212908
University of Heidelberg
Kleopatra Rapti1,2,
Olena Maiakovska1,2,
Jonas Becker1,2,
Joanna Szumska1,2,
Margarita Zayas1,2,
Felix Bubeck1,2,
Jixin Liu1,2,
Emma Gerstmann1,2,
Chiara Krämer1,2,
Ellen Wiedtke1,2,
Dirk Grimm1,2,3,4,5
1Department of Infectious Diseases/Virology, Section Viral Vector Technologies, Medical Faculty, University of Heidelberg,
2BioQuant Center, BQ0030, University of Heidelberg,
3, Cluster of Excellence CellNetworks,
4, German Center for Infection Research (DZIF),
5, German Center for Cardiovascular Research (DZHK)
政策
使用条款
隐私
联系我们
向图书馆推荐
JoVE 新闻简报
JoVE Journal
技术专题合集
JoVE Encyclopedia of Experiments
档案
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
教师资源中心
发表
图书馆员
访问权限
关于 JoVE
版权所属 © 2024 MyJoVE 公司版权所有,本公司不涉及任何医疗业务和医疗服务。